Back

Roche stops work on obesity-drug candidate, returns emugrobart rights to Chugai

Verifying
  • Roche stopped work and returned rights to emugrobart to Chugai.
  • Roche shares fell 1.61%, while Chugai shares dropped 3.84%.
  • Chugai originally discovered emugrobart and licensed it to Roche.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Roche stops work on obesity-drug candidate, returns emugrobart rights to Chugai - CoinPost Terminal